Navigation Links
Electronic Prescribing Saves Patients Money
Date:12/8/2008

It steers doctors toward lower-cost drugs, study finds

MONDAY, Dec. 8 (HealthDay News) -- An electronic prescribing system that tells doctors which drugs are the least expensive can save millions a year, a new study finds.

"One of the challenges physicians face is that they don't know which drugs are preferred or not preferred," said Dr. Michael A. Fischer, an assistant professor of medicine at Harvard Medical School and lead author of a report in the Dec. 8/22 issue of the Archives of Internal Medicine. "The insurance companies involved in the study provided that information by a color code -- green for drugs that were preferred, red for drugs that were not preferred."

The study of 17.4 million prescriptions filled by more than 1.5 million patients of nearly 1,200 Massachusetts physicians found that use of the least expensive drugs -- classified as "tier 1" for the study, such as those available generically -- increased by 3.3 percent when e-prescribing was used. Use of more expensive "tier 2" preferred brand-name drugs decreased by 1.9 percent, and use of "tier 3" non-preferred brand-name drugs decreased by 1.5 percent.

The result was an estimated savings of 70 cents per patient a month -- not much per individual, but it added up to $845,000 a year for every 100,000 people filling prescriptions.

And those savings were possible when just 20 percent of the doctors who had access to e-prescribing used it. "The potential savings increase with more availability and use of e-prescribing; for complete e-prescribing use, the projected savings are $3.91 million per 100,000 patients per year," the report said.

The U.S. government is pushing hard to increase electronic prescribing. Medicare is offering a 2 percent bonus over its regular fees for physicians using such a system in 2009 and 2010. The bonus will be 1 percent for 2011 and 2012, and 0.5 percent for 2013.

A number of different
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. More proof needed of safety and quality of electronic personal health records
2. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
3. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
4. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
5. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
6. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
7. Kaiser Permanente Named Green Electronics Champion by EPA, Green Electronics Council
8. The Cardiovascular Multimedia Network (CVMD) and the International Society of Endovascular Specialists (ISES) Join Forces to Educate Practitioners Worldwide Through Electronic Media
9. Texas Childrens Hospital Selects Hyland Softwares OnBase to Complete Electronic Medical Records Initiative
10. Lakeside Systems Selects Allscripts Electronic Health Record for 100 Physicians
11. Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Electronic Prescribing Saves Patients Money
Electronic Prescribing Saves Patients Money
(Date:12/1/2009)... patients in California are unable to successfully... at hospitals despite recent state legislation int...a new study. , Posing as low-income uninsured pa...less than one-third of the hospitals they approach...er than those allowed under California law, accord...
(Date:12/1/2009)...rdiovascular system tied to academic achievement, ...y News) -- A strong cardiovascular system in young... school grades and more overall success later in l...octors and laypeople know (or should know) the ben..., the authors of a new study, appearing in this we...
(Date:12/1/2009)... ADDISON, Texas, Dec. 1 For many e...ealth care is more than just an employee benefit, ...ployees. Hobby Lobby Stores, Inc. is leading this ...orksite health and wellness center at its corporat...care services directly to employees and their depe...
(Date:12/1/2009)..., SAN DIEGO, Dec. 1 U...of Farming, Nursery and Wellness products is pleas... with Southern California Micro-Lending Institutio...an Skwara, CEO of US Farms, Inc. stated, "We are p...with Angels in Action utilizing our Aloe365.com pr...
(Date:12/1/2009)..., LOS ANGELES, Dec. 1 Gooooooaa...mentines kicks off its 2009/2010 growing season wi...s relationship with kids, soccer. Joy Fawcett - a...l captain the brand,s efforts to celebrate and men...h league sponsorship expansion into Texas and a co...
Breaking Medicine News(10 mins):Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 2Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 3Health News:Olympic Gold Medalist, World Cup Champion and Soccer Hall of Famer Joy Fawcett Sports A New Uniform as an Official Cuties(R) California Mandarin and Clementine Spokes-Mom 4
...oration,(NYSE: AOC ), the world,s leading provid...es, today announced Jim Finnamore will join the fi...ental Services Group, Asia-Pacific.,Based in Singa...215/CGW049LOGO ) , Finnamore brings over 15 ...
...the other, or one is mistaken for the other , ...ho have panic disorder or panic attacks have an in...ut not heart-related deaths, a new study shows. , ...e condition. , People who were younger than 50 whe...
...8, 2008, TooBusyWorking was launched as a next-gen...cal nursing job openings from all major employers ...more local nursing job listings than CareerBuilder...th information detailing commuting distance, shift...
... combination with ribavirin for previously untreat...et medical need , , KENILWORTH, N.J., Dec. 12... announced that the U.S. Food and Drug Administrat...ously untreated patients 3 years of age and older ...
... International, LLC,today announced a new strategi...ific investigator at Henry Ford Hospital Sleep Dis...ill serve as the hotel chain,s resident sleep,expe...ucate consumers about issues,that surround sleeple...
...ance,Company (John Hancock) is reinforcing its com...re insurance (LTCI) training requirements through ...John Hancock began validating,courses through Clea...its Partnership training effort last year, John Ha...
Other Medicine News:Health News:Aon Appoints Environmental Veteran to Oversee Risk Management Services for Clients in Far East, Asia and Australia 2Health News:Aon Appoints Environmental Veteran to Oversee Risk Management Services for Clients in Far East, Asia and Australia 3Health News:Panic Disorder Linked to Higher Risk of Heart Disease 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7Health News:AmericInn Hotels Partners With Nationally Recognized Sleep Expert Dr. Christopher Drake, Announces Launch of 'Sleep Better America' Campaign 2Health News:AmericInn Hotels Partners With Nationally Recognized Sleep Expert Dr. Christopher Drake, Announces Launch of 'Sleep Better America' Campaign 3Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 2Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 3
(Date:12/1/2009)... , ALBUQUERQUE, N.M., Dec. 1 ... laboratory that discovers, develops and markets p...intment of Scott Glenn as chairman of the company,...,, Prior to joining Exagen, Glenn was managing ...of a number of successful biomedical companies inc...
(Date:12/1/2009)... , CHENGDU, China, Dec. 1 /PRNewsw... Inc., (NYSE Amex: TPI ), a manufacturer and supp...TCM") based in Chengdu, China, today,announced tha... Food and Drug,Administration (SFDA) to produce Pe... of 10 ml/tube (SFDA approval number Z20093060) an...
(Date:12/1/2009)... , BEIJING, Dec. 1 /PRNewswire-As...ing provider of biopharmaceutical products in Chin... purchase order for its H1N1 vaccine, PANFLU.1(TM)...n Technology for the national,purchase plan. Under...ce an,additional one million doses of PANFLU.1 (TM...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Indian Prairie School District Awards Contract to Accelify 60563 1Indian Prairie School District Awards Contract to Accelify 60563 2Fred Hutchinson Cancer Research Center Seeks Seattle Area Volunteers for a Stress reduction Study 60559 1Fred Hutchinson Cancer Research Center Seeks Seattle Area Volunteers for a Stress reduction Study 60559 2Early stage HER2 positive breast cancer patients at increased risk of recurrence 60558 1Early stage HER2 positive breast cancer patients at increased risk of recurrence 60558 2Early stage HER2 positive breast cancer patients at increased risk of recurrence 60558 3
...se 2 comparative study showed significant,results ...ass. and WAYNE, N.J., May 02, 2007,/PRNewswire-Fir...e,Pharmaceutical today announced detailed interim ...rim analysis of all patient data,through at least ...,all patients showed that a once-yearly cycle of a...
..., 2007 /PRNewswire/ -- LigoCyte,Pharmaceuticals pr...zation with their influenza virus-like particles (... challenge study. The,company,s data were presente...f vaccine development, at the Tenth Annual Confere...Foundation of Infectious,Diseases in Baltimore. , ...
Other Medicine Technology:Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 2Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 3Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 4Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 5Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 7Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 8Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 9LigoCyte Pharmaceuticals Presents Data Showing Heterosubtypic,Protection Against Influenza Challenge With Virus-Like Particle,Immunization 2
Long-Sleeve Bolero
Diamond Wear™ Abdominal Band/Breast Wrap
Sub Pectoral Breast Augmentation Wrap
Ultra-Comfort Surgical Bra™
Medicine Products: